Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.
Salerno F, Borzio M, Pedicino C, Simonetti R, Rossini A, Boccia S, Cacciola I, Burroughs AK, Manini MA, La Mura V, Angeli P, Bernardi M, Dalla Gasperina D, Dionigi E, Dibenedetto C, Arghittu M; AISF Investigators. Salerno F, et al. Among authors: boccia s. Liver Int. 2017 Jan;37(1):71-79. doi: 10.1111/liv.13195. Epub 2016 Jul 22. Liver Int. 2017. PMID: 27364035
Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in-field multicenter cohort study.
Borzio M, Dionigi E, Vitale A, Rossini A, Marignani M, Fornari F, Vicari S, De Sio I, Farinati F, Bertolini E, Oliveri F, Leandro G, Francica G, Mitra M, Omazzi B, Boccia S, Salmi A, Toldi A, Sacco R. Borzio M, et al. Among authors: boccia s. Liver Int. 2017 Aug;37(8):1184-1192. doi: 10.1111/liv.13392. Epub 2017 Mar 30. Liver Int. 2017. PMID: 28214386
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.
Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, Marenco G, Pistarà R, Salvagnini M, Sangiovanni A. Borzio M, et al. Among authors: boccia s. Dig Liver Dis. 2001 Jan-Feb;33(1):41-8. doi: 10.1016/s1590-8658(01)80134-1. Dig Liver Dis. 2001. PMID: 11303974
Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice.
Salerno F, Cazzaniga M, Merli M, Spinzi G, Saibeni S, Salmi A, Fagiuoli S, Spadaccini A, Trotta E, Laffi G, Koch M, Riggio O, Boccia S, Felder M, Balzani S, Bruno S, Angeli P; Italian Association of the Hospital Gastroenterologists (AIGO) investigators. Salerno F, et al. Among authors: boccia s. J Hepatol. 2011 Dec;55(6):1241-8. doi: 10.1016/j.jhep.2011.03.012. Epub 2011 Apr 13. J Hepatol. 2011. PMID: 21703199
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.
Caraceni P, Tufoni M, Zaccherini G, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Simone L, Svegliati-Baroni G, Fagiuoli S, Laffi G, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Gasbarrini A, De Marco R, Piano S, Nardelli S, Elia C, Roncadori A, Baldassarre M, Bernardi M; ANSWER Study Investigators. Caraceni P, et al. J Hepatol. 2021 Feb;74(2):340-349. doi: 10.1016/j.jhep.2020.08.021. Epub 2020 Aug 24. J Hepatol. 2021. PMID: 32853747 Clinical Trial.
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G, Fagiuoli S, Romanelli RG, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Tortora A, De Marco R, Angelico M, Cacciola I, Elia G, Federico A, Massironi S, Guarisco R, Galioto A, Ballardini G, Rendina M, Nardelli S, Piano S, Elia C, Prestianni L, Cappa FM, Cesarini L, Simone L, Pasquale C, Cavallin M, Andrealli A, Fidone F, Ruggeri M, Roncadori A, Baldassarre M, Tufoni M, Zaccherini G, Bernardi M; ANSWER Study Investigators. Caraceni P, et al. Among authors: boccia s. Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1. Lancet. 2018. PMID: 29861076 Clinical Trial.
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C.
Gramenzi A, Andreone P, Cursaro C, Verucchi G, Boccia S, Giacomoni PL, Galli S, Furlini G, Biselli M, Lorenzini S, Attard L, Bonvicini F, Bernardi M. Gramenzi A, et al. Among authors: boccia s. J Gastroenterol. 2007 May;42(5):362-7. doi: 10.1007/s00535-007-2006-3. Epub 2007 May 25. J Gastroenterol. 2007. PMID: 17530360 Clinical Trial.
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.
Fattovich G, Zagni I, Minola E, Felder M, Rovere P, Carlotto A, Suppressa S, Miracolo A, Paternoster C, Rizzo C, Rossini A, Benedetti P, Capanni M, Ferrara C, Costa P, Bertin T, Pantalena M, Lomonaco L, Scattolini C, Mazzella G, Giusti M, Boccia S, Milani S, Marin R, Lisa Ribero M, Tagger A. Fattovich G, et al. Among authors: boccia s. J Hepatol. 2003 Nov;39(5):843-9. doi: 10.1016/s0168-8278(03)00391-x. J Hepatol. 2003. PMID: 14568269 Clinical Trial.
Lichen planus and interferon therapy for hepatitis C.
Boccia S, Gamberini S, Dalla Libera M, Strumia R, Venturini D. Boccia S, et al. Gastroenterology. 1993 Dec;105(6):1921-2. doi: 10.1016/0016-5085(93)91099-4. Gastroenterology. 1993. PMID: 8253371 No abstract available.
418 results